| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |